您的位置：首页 > 产品中心 > 315-30-0， 别嘌醇
别嘌醇
Allopurinol
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 4063690 | 250 MG | 3230 |
产品别名
315-30-0
别嘌醇
Allopurinol
4-Hydroxypyrazolo(3,4-d)pyrimidine
HPP
1H-Pyrazolo(3,4-d)pyrimidin-4-ol
4-Hydroxypyrazolo[3,4-d]pyrimidine
1H-吡唑并 (3,4-d) 嘧啶-4-醇
4-羟基吡唑并 (3,4-d) 嘧啶
4-羟基吡唑并 [3,4-d] 嘧啶
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C5H4N4O |
| Molecular weight | 136.11 |
| MDL number | MFCD00599413 |
| PubChem Substance ID【PubChem化学物质编号】 | 329748958 |
| NACRES | NA.24 |
| General description【一般描述】 | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. |
| Biochem/physiol Actions【生化/生理作用】 | 黄嘌呤氧化酶和初始嘧啶生物合成的抑制剂。治疗高尿酸血症和痛风的经典药物。 |
| Analysis Note【分析说明】 | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Other Notes【其他说明】 | USP issued SDS can be found here. Sales restrictions may apply. |
产品性质
| grade【等级】 | pharmaceutical primary standard |
| manufacturer/tradename | USP |
| mp | >300 ℃ (lit.) |
| application(s) | pharmaceutical (small molecule) |
| format【格式】 | neat |
| storage temp.【储存温度】 | 15-25℃ |
| SMILES string | O=C1NC=Nc2[nH]ncc12 |
| InChI | 1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10) |
| InChI key | OFCNXPDARWKPPY-UHFFFAOYSA-N |
| Gene Information | human ... XDH(7498) |
安全信息
| Pictograms【象形图】 | GHS06 |
| Signal word【警示用语：】 | Danger |
| Hazard Statements | H301 - H317 |
| Precautionary Statements | P261 - P264 - P270 - P280 - P301 + P310 - P302 + P352 |
| Hazard Classifications【危险分类】 | Acute Tox. 3 Oral - Skin Sens. 1 |
| Storage Class Code【储存分类代码】 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| WGK | WGK 2 |
